Q: How would you generally describe the second quarter results from the companies in the Canada and the United States markets.
Clayton
    Clayton
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
 CCL Industries Inc. Unlimited Class B Non-Voting Shares (CCL.B $78.25)
                CCL Industries Inc. Unlimited Class B Non-Voting Shares (CCL.B $78.25)
    
        
 Knight Therapeutics Inc. (GUD $5.86)
                Knight Therapeutics Inc. (GUD $5.86)